Thromboembolic Prophylaxis With Danaparoïd (Orgaran®) in a High-Thrombosis-Risk Pregnant Woman With a History of Heparin-Induced Thrombocytopenia (HIT) and Widal' s Disease

Laurent Macchi, R Sarfati, M. Guicheteau, V. Chamlian, O. Pourrât, Yves Gruel, G Magnin, A. Brizard, C. Boinot

Clinical and Applied Thrombosis/Hemostasis · 2000 · 17 citations · 9 references

Concepts

Abstract

There is no consensus concerning thromboembolic prophylaxis in high-risk pregnant women with a previous history of heparin-induced thrombocytopenia. An alternative anticoagulant therapy is danaparoïd, whereas unfractioned and low-molecular-weight heparin therapy is contraindicated. We report a case of successful thrombosis prophylaxis using danaparoïd in a high-thrombosis-risk pregnant woman with a history of heparin-induced thrombocytopenia during a previous pregnancy and Widal's disease.

References

9